Skip to main content
Log in

Methamphetamine: a European Union perspective in the global context

  • Excerpts
  • Published:
Trends in Organized Crime Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. However, a decision by the State Institute for Drug Control of the Czech Republic in May 2009 imposed restrictions on the sale of pseudo-ephedrine containing OTC products. These include prohibiting mail order sales, setting a maximum dose sold per patient per month (1 800 mg of pseudo-ephedrine), and registering sales in a ‘central repository of electronic prescriptions’ also containing data on patients.

  2. The Russian Federation reported the seizure of 137 methamphetamine sites (referred to as ‘Pervitin’ and ‘Ephedron’ sites) in 2007; all were kitchen-type labs.

  3. E-mail from the National Drug Headquarters of the Czech Republic police, 18 March 2009.

  4. Statistical data for 2008 is provisional, as not all Member States have yet provided information to Europol.

  5. One of the three methamphetamine production sites reported by Poland in 2008 used the red phosphorus production method, whilst the methods of production of the remainder are unknown.

  6. In May 2009, the Lithuanian authorities seized a mid-size methamphetamine production site in the Kaunas region, together with approximately 100 kg of high purity methamphetamine. The drugs were intended for the Norwegian market.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Methamphetamine: a European Union perspective in the global context. Trends Organ Crim 13, 240–248 (2010). https://doi.org/10.1007/s12117-010-9104-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12117-010-9104-y

Navigation